KRAS and breast carcinoma: Our recent study described that following cellular stress, such as oncogenic KRAS expression, EGF treatment and ionizing radiation exposure, RSK translocates to the nucleus and phosphorylates nuclear YB-1 in breast cancer cells, but YB-1 does not translocate to the nucleus in response to these stimuli [29].